Non-Myeloablative Stem Cell Transplants
|
Dose-reduced conditioning for allogeneic blood stem cell transplantation: durable engraftment without antithymocyte globulin
|
119
|
M Bornhäuser, C Thiede, U Schuler, U Platzbecker, J Freiberg-Richter, A Helwig, R Plettig, C Röllig, R Naumann, F Kroschinsky, A Neubauer & G Ehninger
|
Abstract Full Article PDF
|
 |
|
Progenitor Cell Mobilisation
|
Mobilization kinetics of peripheral blood progenitor cells after IAPVP-16 salvage chemotherapy plus G-CSF in lymphoproliferative disorders
|
127
|
A Altés, R López, R Martino, C Martinez, E Cabezudo, L Muñoz, A Santamaría, G Perea, J Briones, A Salar, A Sureda, S Brunet, P Madoz & J Sierra
|
Abstract Full Article PDF
|
 |
|
Breast Cancer
|
The feasibility of high-dose chemotherapy in breast cancer patients with impaired left ventricular function
|
133
|
M Rose, FA Lee, A Gollerkeri, E D'Andrea, A Psyrri, T Bdolah-Abram & BA Burtness
|
Abstract Full Article PDF
|
 |
Phase 1 study of pegylated recombinant human megakaryocyte growth and development factor (PEG-rHuMGDF) in breast cancer patients after autologous peripheral blood progenitor cell (PBPC) transplantation
|
141
|
B Bolwell, J Vredenburgh, B Overmoyer, C Gilbert, L Chap, DM Menchaca, S Cruickshank & J Glaspy
|
Abstract Full Article PDF
|
 |
|
Acute Leukaemia
|
High frequency of extramedullary relapse of acute leukemia after allogeneic bone marrow transplantation
|
147
|
K-H Lee, J-H Lee, S Kim, J-S Lee, S-H Kim & W-K Kim
|
Abstract Full Article PDF
|
 |
|
Autografting
|
High-dose carmustine, thiotepa and etoposide followed by autologous bone marrow rescue for the treatment of high risk central nervous system tumors
|
153
|
V Papadakis, IJ Dunkel, LD Cramer, E Kramer, E Papadopoulos, S Goldman, RJ Packer, M Willoughby, D Baker, J Garvin, S Strandjord, P Coccia, AM Kaplan, M Klemperer & JL Finlay
|
Abstract Full Article PDF
|
 |
|
Graft-Versus-Host Disease
|
Tacrolimus (FK506) and methotrexate as prophylaxis for acute graft-versus-host disease in pediatric allogeneic stem cell transplantation
|
161
|
G Yanik, JE Levine, V Ratanatharathorn, R Dunn, J Ferrara & RJ Hutchinson
|
Abstract Full Article PDF
|
 |
|
Immune Recovery
|
Immune reconstitution following high-dose chemotherapy with stem cell rescue in patients with advanced breast cancer
|
169
|
D Avigan, Z Wu, R Joyce, A Elias, P Richardson, D McDermott, J Levine, L Kennedy, N Giallombardo, D Hurley, J Gong & D Kufe
|
Abstract Full Article PDF
|
 |
Reconstitution of  T cell repertoire diversity after human allogeneic hematopoietic cell transplantation and the role of peripheral expansion of mature T cell population in the graft
|
177
|
M Hirokawa, T Horiuchi, Y Kawabata, A Kitabayashi & AB Miura
|
Abstract Full Article PDF
|
 |
|
Post-Transplant Complications
|
Cardiac systolic function before and after hematopoietic stem cell transplantation
|
187
|
S Lehmann, B Isberg, P Ljungman & C Paul
|
Abstract Full Article PDF
|
 |
Liver disease during the first post-transplant year in bone marrow transplantation recipients: retrospective study
|
193
|
BK Kim, KW Chung, HS Sun, JG Suh, WS Min, CS Kang, SI Sim, WS Shin & CC Kim
|
Abstract Full Article PDF
|
 |
Early intervention in post-transplant lymphoproliferative disorders based on EpsteinBarr viral load
|
199
|
Y Hoshino, H Kimura, K Kuzushima, T Tsurumi, K Nemoto, A Kikuta, Y Nishiyama, S Kojima, T Matsuyama & T Morishima
|
Abstract Full Article PDF
|
 |
Double-blind, randomized, parallel-group study on the efficacy and safety of oral granisetron and oral ondansetron in the prophylaxis of nausea and vomiting in patients receiving hyperfractionated total body irradiation
|
203
|
TR Spitzer, CJ Friedman, W Bushnell, SR Frankel & J Raschko
|
Abstract Full Article PDF
|
 |
Febrile neutropenia in allogeneic and autologous peripheral blood stem cell transplantation and conventional chemotherapy for malignancies
|
211
|
H Çelebi, H Akan, E Akça layan, C Üstün & M Arat
|
Abstract Full Article PDF
|
 |
Severe oesophagitis after allogeneic bone marrow transplantation for Fanconi's anemia
|
215
|
I Yakoub-Agha, G Damaj, L Garderet, J Bonnet, A Devergie, H Esperou, P Ribaud, G Socie & E Gluckman
|
Abstract Full Article PDF
|
 |
|
Case Reports
|
Long-term follow-up of two children with a variant of mild autosomal recessive osteopetrosis undergoing bone marrow transplantation
|
219
|
G Dini, R Floris, A Garaventa, M Oddone, F De Stefano, R De Marco, E Calcagno, M Faraci, F Claudiani, L Manfredini, S Dallorso, E Lanino & G Morreale
|
Abstract Full Article PDF
|
 |
Brucellosis transmitted by bone marrow transplantation
|
225
|
M Ertem, AE Kürekçi, D Aysev, E Ünal & A Ikincio ullar
|
Abstract Full Article PDF
|
 |
Successful autologous bone marrow transplant without the use of blood product support
|
227
|
KK Ballen, PA Ford, H Waitkus, RVB Emmons, W Levy, P Doyle, FM Stewart, PJ Quesenberry & PS Becker
|
Abstract Full Article PDF
|
 |
Inappropriate antidiuretic hormone secretion, abdominal pain and disseminated varicella-zoster virus infection: an unusual triad in a patient 6 months post mini-allogeneic peripheral stem cell transplant for chronic myeloid leukemia
|
231
|
F Szabó, N Horvath, S Seimon & T Hughes
|
Abstract Full Article PDF
|
 |
Unrelated partially matched peripheral blood stem cell transplantation with highly purified CD34+ cells in a child with WiskottAldrich syndrome
|
235
|
W Schwinger, Ch Urban, H Lackner, R Kerbl, M Benesch, HJ Dornbusch, P Sovinz, M Schumm & R Handgretinger
|
Abstract Full Article PDF
|
 |
Erythema exsudativum multiforme induced by granulocyte colony-stimulating factor in an allogeneic peripheral blood stem cell donor
|
239
|
T Mori, N Sato, R Watanabe, S Okamoto & Y Ikeda
|
Abstract Full Article PDF
|
 |
|
Correspondence
|
Secondary myelodysplastic syndromes following peripheral blood stem cell transplantation: morphological, cytogenetic and clonality evaluation and the limitation of FAB criteria
|
241
|
L Laurenti, G d'Onofrio, S Sica, P Chiusolo, G Zini, N Piccirillo, M Zolliino, M Garzia, F Sora & G Leone
|
Full Article PDF
|
 |
 |
 |